Juan Ignacio Martínez-Salamanca, MD, PhD, is a Urologist, Men´s Health Expert focused in Urologic Oncology and a major contributor to the Focalyx paradigm.
Since 2007, he serves as an Attending Physician-Surgeon in the Universidad Autonoma de Madrid Affiliated Puerta de Hierro Hospital (Madrid, Spain) and is the founder of CUMQ and Lyx centers of urological excellence in Madrid.
Dr Martinez-Salamanca earned his MD degree, from Universidad Complutense, Madrid, Spain. He completed his residency program in Urology at the Gregorio Maranon Hospital in Madrid-Spain. Upon completing his fellowship at the Cornell University Department of Urology (New York, NY) he gained his European Ph.D (Doctor Europeus) “Cum Laude” from UAM in 2011 on the dissertation “Survival and Perioperative Predictive Model in Patients with Renal Cell Carcinoma and Venous Extension"
Dr. Martínez-Salamanca has a profound commitment to research. His interests are broad and include: erectile dysfunction outcomes after radical prostatectomy, stem cell therapy, peyronie´s disease, renal cell carcinoma with venous involvement and prostate cancer diagnosis and treatment including prostate fusion biopsy and image guided therapy. In fact, this extensive work propelled the foundation by him and collaborators of the “International Renal Cell Carcinoma Venous Thrombus Consortium” that currently includes 23 institutions around the world. Under his leadership this consortium has produced over 25 analysts presented or published in top scientific journals.
He is the author of over 105 publications in urology as well as contributing chapters to several medical textbooks. He served as International Associated Editor (2008–2014) of Archivos Españoles de Urología and currently serves an Assistant Editor of the Journal of Sexual Medicine. Also served from 2009, as Editor of the European Society for Sexual Medicine) Newsletter and from 2015 as Editor-in-Chief or Revista Internacional de Andrología